Latest News and Press Releases
Want to stay updated on the latest news?
-
CAMBRIDGE, Mass., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology ("Pyxis" or the “Company”) today announced the recent appointment of Pamela Yanchik Connealy, M.B.A., as its Chief Financial...
-
Pyxis Oncology Strengthens Leadership Team with Executive and Scientific Advisory Board Appointments
– Steve Monks, Ph.D., appointed as Chief Technical Officer, brings 20+ years in drug development and CMC, Quality, and Regulatory operations – – Ritu Shah, PMP, appointed as Chief Operating Officer,...
-
LEXINGTON, Mass. and CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Alloy Therapeutics (“Alloy”) and Pyxis Oncology ("Pyxis") today announced the formation of a joint venture named Kyma...
-
CAMBRIDGE, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology ("Pyxis" or the "Company") today announced the targets of its three antibody-drug conjugate (ADC) candidates along with additional...
-
CAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology ("Pyxis" or the "Company") today announced that it will host a key opinion leader (KOL) webinar on antibody-drug conjugates on...
-
-- New round enables Pyxis to advance differentiated antibody-drug conjugate (ADC) and immuno-oncology (I/O) programs to next value inflection point -- -- In addition to recently announced...
-
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology (“Pyxis” or the "Company”) today announced that it has entered into a worldwide license agreement with Pfizer Inc. (NYSE:PFE) for...